← Open Payments lookup

MICHAEL DALY: Open Payments

NPI 1659748077 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,649 in 74 payments from 11 companies in 2025. Trend: 2023 $1,068 · 2024 $774 · 2025 $1,649

Food & beverage: $1,649
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$407
Vanda Pharmaceuticals Inc.8$296
Otsuka America Pharmaceutical, Inc.11$221
E.R. Squibb & Sons, L.L.C.8$196
ABBVIE INC.12$156
Alkermes, Inc.10$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$79
Axsome Therapeutics, Inc.3$47
Janssen Pharmaceuticals, Inc2$36
Teva Pharmaceuticals USA, Inc.2$31

Products named: INGREZZA, FANAPT, COBENFY, ABILIFY ASIMTUFII, VRAYLAR, ARISTADA, CAPLYTA, Auvelity.

Industry payments across GA — which companies pay providers there.